Research Article

Analytical and bioanalytical HPLC method for simultaneous estimation of 5-fluorouracil and sonidegib

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India

Search for more papers by this author

Aswathi R Hegde

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India

Search for more papers by this author

Sadhana P Mutalik

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India

Search for more papers by this author

Swati Biswas

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Medchal, Hyderabad, 500078, Telangana, India

Search for more papers by this author

Srinivas Mutalik

*Author for correspondence:

E-mail Address: ss.mutalik@manipal.edu

https://orcid.org/0000-0002-0642-1928

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India

Search for more papers by this author

Published Online:17 Nov 2021https://doi.org/10.4155/bio-2021-0212

View article

Abstract

Aim: To develop a new sensitive RP-HPLC method for simultaneous estimation of 5-fluorouracil (5-FU) and sonidegib (SDG). Materials & methods: Analytical and bioanalytical methods for simultaneous quantification of 5-FU and SDG in bulk, nanoformulations and in rat plasma were developed and validated using a gradient elution technique. Results: Separation of the analytes was effected on a Luna^® C18 LC column using a mobile mixture comprising acetonitrile and acidified water. 5-FU and SDG were extracted from plasma matrix using liquid–liquid extraction. The applicability of the method was verified through single-dose oral pharmacokinetic study in Wistar rats. Conclusion: The developed methods allow a specific, sensitive and steady analytical procedure for the simultaneous estimation of 5-FU and SDG in nanoformulations and biological matrix.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Nohynek GJ, Schaefer H. Benefit and risk of organic ultraviolet filters. Regul. Toxicol. Pharmacol. 33(3), 285–299 (2001).
Medline CASGoogle Scholar
2. The American Cancer Society. Melanoma skin cancer statistics. https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html • Describes the pathophysiology of skin cancer.
Google Scholar
3. Mayo Clinic. Skin cancer - diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/skin-cancer/diagnosis-treatment/drc-20377608
Google Scholar
4. Wikipedia. Fluorouracil. https://en.wikipedia.org/wiki/Fluorouracil • Describes the physicochemical properties of drug 5-fluorouracil.
Google Scholar
5. Chinembiri TN, Gerber M, du Plessis L, du Preez J, du Plessis J. Topical delivery of 5-fluorouracil from Pheroid™ formulations and the in vitro efficacy against human melanoma. AAPS PharmSciTech. 16(6), 1390–1399 (2015).
Medline CASGoogle Scholar
6. The American Cancer Society. Basal & squamous cell local treatment. Skin cancer local treatments. https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/treating/other-than-surgery.html
Google Scholar
7. Brancaccio G, Pea F, Moscarella E, Argenziano G. Sonidegib for the treatment of advanced basal cell carcinoma. Front. Oncol. 10 (2020). https://www.frontiersin.org/articles/10.3389/fonc.2020.582866/full • Reports the clinical pharmacokinetics of the drug sonidegib.
MedlineGoogle Scholar
8. Zhao D, Wu J, Li C, Zhang H, Li Z, Luan Y. Precise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapy. Colloids Surf. B Biointerfaces 155, 51–60 (2017). •• Describes the use of two anticancer drugs with different anticancer mechanism for effective treatment.
Medline CASGoogle Scholar
9. Gamal A, Saeed H, El-Ela FIA, Salem HF. Improving the antitumor activity and bioavailability of sonidegib for the treatment of skin cancer. Pharm. 13, article no. 1560, 1–16 (2021).
Google Scholar
10. Siddalingam R, Chidambaram K. Topical nano-delivery of 5-fluorouracil: preparation and characterization of water-in-oil nanoemulsion. Trop. J. Pharm. Res. 15(11), 2311 (2016).
CASGoogle Scholar
11. Patel G, Yadav BKN. Study of 5-fluorouracil loaded chitosan nanoparticles for treatment of skin cancer. Recent Pat. Nanotechnol. 14(3), 210–224 (2020).
Medline CASGoogle Scholar
12. Mohammad O, Faisal SM, Ahmad N et al. Bio-mediated synthesis of 5-FU based nanoparticles employing orange fruit juice: a novel drug delivery system to treat skin fibrosarcoma in model animals. Sci. Rep. 9(1), 1–14 (2019). http://www.nature.com/articles/s41598-019-48180-7
Medline CASGoogle Scholar
13. Khallaf RA, Salem HF, Abdelbary A. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Deliv. 23(9), 3452–3460 (2016).
Medline CASGoogle Scholar
14. Park J, Kim Y-C. Topical delivery of 5-fluorouracil-loaded carboxymethyl chitosan nanoparticles using microneedles for keloid treatment. Drug Deliv. Transl. Res. 11, 205–213 (2021). http://link.springer.com/10.1007/s13346-020-00781-w
Medline CASGoogle Scholar
15. Ganguly K, Kulkarni AR, Aminabhavi TM. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats. Drug Deliv. 23(8), 2838–2851 (2016).
Medline CASGoogle Scholar
16. Zufía L, Aldaz A, Castellanos C, Giráldez J. Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection: validation for application in clinical pharmacokinetic studies. Ther. Drug Monit. 25(2), 221–228 (2003).
Medline CASGoogle Scholar
17. Breda M, Barattè S. A review of analytical methods for the determination of 5-fluorouracil in biological matrices. Anal. Bioanal. Chem. 397(3), 1191–1201 (2010).
Medline CASGoogle Scholar
18. Reddy LS. Analytical method development & validation for the estimation of 5-fluorouracil by RP-HPLC. Creative J. Pharm. Res. 1, 139–150 (2015).
Google Scholar
19. Serve KM, Yáñez JA, Remsberg CM, Davies NM, Black ME. Development and validation of a rapid and sensitive HPLC method for the quantification of 5-fluorocytosine and its metabolites. Biomed. Chromatogr. 24(5), 556–561 (2010).
Medline CASGoogle Scholar
20. Deshpande MM, Kasture VS, Mohan MJ, Chavan M. Bioanalytical method development and validation: a review. In: Recent Advances in Analytical Chemistry. Ince MKaplan IO (Eds). IntechOpen, London, UK (2019). https://www.intechopen.com/books/recent-advances-in-analytical-chemistry/bioanalytical-method-development-and-validation-a-review
Google Scholar
21. Zhai Q-Q, Gong G-Q, Luo Y et al. Determination of SNX-2112, a selective Hsp90 inhibitor, in plasma samples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J. Pharm. Biomed. Anal. 53(4), 1048–1052 (2010).
Medline CASGoogle Scholar
22. Kumar SV, Rudresha G, Gurav S et al. Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats: quantitation of abiraterone in rat plasma by HPLC. Biomed. Chromatogr. 27(2), 203–207 (2013).
Medline CASGoogle Scholar
23. Managuli RS, Kumar L, Chonkar AD et al. Development and Validation of a Stability-Indicating RP-HPLC method by a statistical optimization process for the quantification of asenapine maleate in lipidic nanoformulations. J. Chromatogr. Sci. 54(8), 1290–1300 (2016).
Medline CASGoogle Scholar
24. Managuli RS, Gourishetti K, Shenoy RR, Koteshwara KB, Reddy MS, Mutalik S. Preclinical pharmacokinetics and biodistribution studies of asenapine maleate using novel and sensitive RP–HPLC method. Bioanalysis 9(14), 1037–1047 (2017). •• Explains the systematic development and validation of an RP-HPLC-based bioanalytical method.
CASGoogle Scholar
25. Sharma DS, Wadhwa S, Singh SK, Ramanunny A, Kumar R. Estimation of 5-fluorouracil by high-performance liquid chromatography reversed-phase validated method. Res. J. Pharm. Technol. 13(9), 4249 (2020).
Google Scholar
26. Semail N-F, Abdul Keyon AS, Saad B et al. Analytical method development and validation of anticancer agent, 5-fluorouracil, and its metabolites in biological matrices: an updated review. J. Liq. Chromatogr. Relat. Technol. 43(15–16), 562–579 (2020).
CASGoogle Scholar
27. Murugan S, Vetrichelvan T. Development and validation of uv spectroscopic method for the determination of sonidegib in bulk and pharmaceutical dosage form. Res. J. Pharm. Technol. 13(10), 4836 (2020).
Google Scholar
28. Jana K, Mahanti B. Development and validation of a new improved RP-HPLC method for estimation of rosuvastatin calcium in pharmaceutical dosage form. Res. J. Pharm. Technol. 13(6), 2886 (2020).
Google Scholar
29. Patil RB, Deshmukh TA, Patil VR. Stability indicating HPLC method for dapoxetine HCl in bulk and in formulation. 6(5), 687–690 (2014).
Google Scholar
30. Jayaseelan S, Suresh S, Sathishkumar G, Sekar V, Perumal P. Bioanalytical method development and validation of Lamivudine by RP-HPLC method. Int. J. Chem. Tech. Res. 2, 163–167 (2010).
CASGoogle Scholar
31. Murphy RF, Balis FM, Poplack DG. Stability of 5-fluorouracil in whole blood and plasma. Clin. Chem. 33(12), 2299–2300 (1987).
Medline CASGoogle Scholar
32. Siddiqui MR, AlOthman ZA, Rahman N. Analytical techniques in pharmaceutical analysis: a review. Arabian J. Chem. 10, S1409–S1421 (2017).
CASGoogle Scholar
33. de Mattos AC, Khalil NM, Mainardes RM. Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles. Br. J. Pharm. Sci. 49(1), 117–126 (2013).
CASGoogle Scholar
34. Sharma MK, Murugesan M. Forced degradation study an essential approach to develop stability indicating method. J Chromatogr Sep Tech 8(1), 1–3. https://www.longdom.org/abstract/forced-degradation-study-an-essential-approach-to-develop-stabilityindicating-method-51452.html
Google Scholar
35. Sinha V, Kumar R, Bhinge J. A stability-indicating RP-HPLC assay method for 5-fluorouracil. Indian J. Pharm. Sci. 71(6), 630 (2009).
Medline CASGoogle Scholar
36. Alanazi FK, Eldeen Yassin A, El-Badry M, Mowafy HA, Alsarra IA. Validated high-performance liquid chromatographic technique for determination of 5-fluorouracil: applications to stability studies and simulated colonic media. J. Chromatogr. Sci. 47(7), 558–563 (2009).
Medline CASGoogle Scholar
37. Hegde AR, Padya BS, Soman S, Mutalik S. A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics. J. Anal. Sci. Technol. 12(1), 25 (2021). • Discusses the systematic development of HPLC-based bioanalytical method for the estimation of drugs.
CASGoogle Scholar
38. Liu Y, Zhao D, Sun M et al. Covalently mucoadhesive amphiphilic prodrug of 5-fluorouracil for enhanced permeation and improved oral absorption. Drug Deliv. Transl. Res. 8(3), 645–656 (2018).
Medline CASGoogle Scholar
39. Fendrich V, Wiese D, Waldmann J et al. Hedgehog inhibition with the orally bioavailable smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms. Ann. Surg. 254(5), 818–823 (2011).
MedlineGoogle Scholar
40. Milano G, Chamorey A-L. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol. Int. 19(1), 177–189 (2002).
Medline CASGoogle Scholar
41. European Medicines Agency. Odomzo. https://www.ema.europa.eu/en/medicines/human/EPAR/odomzo
Google Scholar

Vol. 14, No. 1

Metrics

Downloaded 124 times

History

Received 29 September 2021

Accepted 1 November 2021

Published online 17 November 2021

Published in print January 2022

Information

Keywords

Acknowledgments

The authors are thankful to: All India Council for Technical Education (AICTE), Government of India, New Delhi for providing National Doctoral Fellowship to Bharath Singh Padya; and Department of Science and Technology (DST), Government of India, New Delhi for providing DST-INSPIRE Fellowship to Sadhana P Mutalik.

Financial & competing interests disclosure

The authors also thank Manipal College of Pharmaceutical Sciences and Manipal Academy of Higher Education, Manipal for providing financial support and research facilities. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

PDF download